Most Recent
Coles urges court not to second guess its ‘commercial’ judgment
Facing claims it misled customers with its 'Down Down' pricing, Coles has urged the court not to second guess its judgment, but a judge overseeing the case has said competitive pressures do not excuse misleading promotions.
Cor Cordis sued by ex-chair who claims firm undervalued WIP
The former chair of Cor Cordis has sued the insolvency firm, claiming it passed resolutions in “bad faith” that reduced the value of its work in progress from $23 million to $12.7 million to avoid paying out his proper retirement entitlements. 
Court tosses greenwashing case against Santos over net zero claims
A court has tossed a landmark greenwashing case against Santos alleging it misled investors by falsely representing that it had a plausible path to net zero by 2040.
Used car owners can sue for reduction in value damages in Ford class action
Deciding an issue that might take a class action against Ford to the High Court for a second time, a judge has found that used car owners can sue under the same consumer guarantee as someone who bought a new car. 
Mobil Oil hit with $16M penalty for misleading consumers about fuel
A judge has ordered Mobil Oil to pay an agreed penalty of $16 million for running ads in far north Queensland over a period of four years falsely claiming that it was supplying a specific brand of fuel with added benefits.
Coles advertised ‘utterly misleading’ discounts to compete with Woolworths, says ACCC
Coles changed its marketing policies after being concerned it could not compete with Woolworths, a court has heard on the first day of trial in the consumer regulator’s case over the supermarket's “utterly misleading” discounts.
CBA to file cross-appeal with High Court in shareholder class actions
CBA plans to file a cross-appeal in the class actions before the High Court, contending the shareholders -- who argue they should have won their loss case -- failed to establish disclosure breaches at the threshold.
AstraZeneca wins injunction against Pharmacor’s generic diabetes drug
AstraZeneca has won an interlocutory injunction barring Pharmacor from making a generic version of its blockbuster diabetes drug Forxiga while a patent case over the drug proceeds.
Twitter defeats case over replies to alleged defamatory tweets
A judge has ruled that a self-represented litigant who settled proceedings against Twitter in 2021 over alleged defamatory tweets cannot pursue a case over replies later made to those tweets.
High Court to hear appeal in CBA shareholder class actions
The High Court has agreed to weigh in on two failed shareholder class actions against the Commonwealth Bank, in a case that could clarity the elusive test for damages in shareholder class actions.